Uneven age effects of [18F]FP-CIT binding in the striatum of Parkinson’s disease

Objective Dopamine transporter (DAT) imaging shows age-related decline of ligand binding in the normal striatum, a decline attributed to regulatory changes. We investigated if similar changes occur in the striatum of Parkinson’s disease (PD) patients, using PET and [ 18 F]FP-CIT, a ligand for DAT. M...

Full description

Saved in:
Bibliographic Details
Published inAnnals of nuclear medicine Vol. 28; no. 9; pp. 874 - 879
Main Authors Lee, Chong S., Kim, Su-Jeong, Oh, Seung Jun, Kim, Hye Ok, Yun, Sung-Cheol, Doudet, Doris, Kim, Jae Seung
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.11.2014
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0914-7187
1864-6433
DOI10.1007/s12149-014-0882-1

Cover

Abstract Objective Dopamine transporter (DAT) imaging shows age-related decline of ligand binding in the normal striatum, a decline attributed to regulatory changes. We investigated if similar changes occur in the striatum of Parkinson’s disease (PD) patients, using PET and [ 18 F]FP-CIT, a ligand for DAT. Methods We performed [ 18 F]FP-CIT PET in 39 drug-naïve, de novo PD patients (age 56.0 ± 11.6 years, mean ± SD) and 34 healthy control subjects (age 52.3 ± 17.8). Parkinsonism was assessed by UPDRS III and Purdue pegboard. Binding ratios of [ 18 F]FP-CIT were obtained in the putamen and caudate using the occipital cortex as reference. Results Mean [ 18 F]FP-CIT binding ratios in PD were 3.76 ± 0.74 (mean ± SD) in the putamen and 6.80 ± 1.05 in the caudate nucleus, significantly smaller than those in the healthy control (9.20 ± 1.38, 8.66 ± 1.12, respectively; p  < 0.001 vs. healthy control for both). Regression analysis of [ 18 F]FP-CIT binding ratios on age in healthy subjects showed significant correlations in the putamen ( p  < 0.001) and caudate nucleus ( p  < 0.001). Similar analysis in PD patients also showed significant correlations in the putamen ( p  = 0.015) and caudate nucleus ( p  = 0.018). The slope of regression in the putamen was −0.061 in the healthy control and −0.017 in PD, with significant differences between the two groups ( p  = 0.0003). In contrast, the regression slope in the caudate nucleus was −0.040 in the healthy control group, and −0.032 in the PD group with no significant differences between the two groups. Conclusions Striatal [ 18 F]FP-CIT binding showed significant age affects in patients with de novo PD after standardization for the severity of disease. The age effects were significantly smaller in PD patients than those in healthy subjects, but only in the putamen, not in the caudate nucleus. Given that age-related attrition of DA neurons is even in normal striatum, the uneven age effects in the parkinsonian striatum are likely to reflect the superimposition of disease-driven compensation on the aging effect.
AbstractList Objective Dopamine transporter (DAT) imaging shows age-related decline of ligand binding in the normal striatum, a decline attributed to regulatory changes. We investigated if similar changes occur in the striatum of Parkinson’s disease (PD) patients, using PET and [ 18 F]FP-CIT, a ligand for DAT. Methods We performed [ 18 F]FP-CIT PET in 39 drug-naïve, de novo PD patients (age 56.0 ± 11.6 years, mean ± SD) and 34 healthy control subjects (age 52.3 ± 17.8). Parkinsonism was assessed by UPDRS III and Purdue pegboard. Binding ratios of [ 18 F]FP-CIT were obtained in the putamen and caudate using the occipital cortex as reference. Results Mean [ 18 F]FP-CIT binding ratios in PD were 3.76 ± 0.74 (mean ± SD) in the putamen and 6.80 ± 1.05 in the caudate nucleus, significantly smaller than those in the healthy control (9.20 ± 1.38, 8.66 ± 1.12, respectively; p  < 0.001 vs. healthy control for both). Regression analysis of [ 18 F]FP-CIT binding ratios on age in healthy subjects showed significant correlations in the putamen ( p  < 0.001) and caudate nucleus ( p  < 0.001). Similar analysis in PD patients also showed significant correlations in the putamen ( p  = 0.015) and caudate nucleus ( p  = 0.018). The slope of regression in the putamen was −0.061 in the healthy control and −0.017 in PD, with significant differences between the two groups ( p  = 0.0003). In contrast, the regression slope in the caudate nucleus was −0.040 in the healthy control group, and −0.032 in the PD group with no significant differences between the two groups. Conclusions Striatal [ 18 F]FP-CIT binding showed significant age affects in patients with de novo PD after standardization for the severity of disease. The age effects were significantly smaller in PD patients than those in healthy subjects, but only in the putamen, not in the caudate nucleus. Given that age-related attrition of DA neurons is even in normal striatum, the uneven age effects in the parkinsonian striatum are likely to reflect the superimposition of disease-driven compensation on the aging effect.
Dopamine transporter (DAT) imaging shows age-related decline of ligand binding in the normal striatum, a decline attributed to regulatory changes. We investigated if similar changes occur in the striatum of Parkinson's disease (PD) patients, using PET and [(18)F]FP-CIT, a ligand for DAT. We performed [(18)F]FP-CIT PET in 39 drug-naïve, de novo PD patients (age 56.0 ± 11.6 years, mean ± SD) and 34 healthy control subjects (age 52.3 ± 17.8). Parkinsonism was assessed by UPDRS III and Purdue pegboard. Binding ratios of [(18)F]FP-CIT were obtained in the putamen and caudate using the occipital cortex as reference. Mean [(18)F]FP-CIT binding ratios in PD were 3.76 ± 0.74 (mean ± SD) in the putamen and 6.80 ± 1.05 in the caudate nucleus, significantly smaller than those in the healthy control (9.20 ± 1.38, 8.66 ± 1.12, respectively; p < 0.001 vs. healthy control for both). Regression analysis of [(18)F]FP-CIT binding ratios on age in healthy subjects showed significant correlations in the putamen (p < 0.001) and caudate nucleus (p < 0.001). Similar analysis in PD patients also showed significant correlations in the putamen (p = 0.015) and caudate nucleus (p = 0.018). The slope of regression in the putamen was -0.061 in the healthy control and -0.017 in PD, with significant differences between the two groups (p = 0.0003). In contrast, the regression slope in the caudate nucleus was -0.040 in the healthy control group, and -0.032 in the PD group with no significant differences between the two groups. Striatal [(18)F]FP-CIT binding showed significant age affects in patients with de novo PD after standardization for the severity of disease. The age effects were significantly smaller in PD patients than those in healthy subjects, but only in the putamen, not in the caudate nucleus. Given that age-related attrition of DA neurons is even in normal striatum, the uneven age effects in the parkinsonian striatum are likely to reflect the superimposition of disease-driven compensation on the aging effect.
Dopamine transporter (DAT) imaging shows age-related decline of ligand binding in the normal striatum, a decline attributed to regulatory changes. We investigated if similar changes occur in the striatum of Parkinson's disease (PD) patients, using PET and [^sup 18^F]FP-CIT, a ligand for DAT. We performed [^sup 18^F]FP-CIT PET in 39 drug-naïve, de novo PD patients (age 56.0 ± 11.6 years, mean ± SD) and 34 healthy control subjects (age 52.3 ± 17.8). Parkinsonism was assessed by UPDRS III and Purdue pegboard. Binding ratios of [^sup 18^F]FP-CIT were obtained in the putamen and caudate using the occipital cortex as reference. Mean [^sup 18^F]FP-CIT binding ratios in PD were 3.76 ± 0.74 (mean ± SD) in the putamen and 6.80 ± 1.05 in the caudate nucleus, significantly smaller than those in the healthy control (9.20 ± 1.38, 8.66 ± 1.12, respectively; p < 0.001 vs. healthy control for both). Regression analysis of [^sup 18^F]FP-CIT binding ratios on age in healthy subjects showed significant correlations in the putamen (p < 0.001) and caudate nucleus (p < 0.001). Similar analysis in PD patients also showed significant correlations in the putamen (p = 0.015) and caudate nucleus (p = 0.018). The slope of regression in the putamen was -0.061 in the healthy control and -0.017 in PD, with significant differences between the two groups (p = 0.0003). In contrast, the regression slope in the caudate nucleus was -0.040 in the healthy control group, and -0.032 in the PD group with no significant differences between the two groups. Striatal [^sup 18^F]FP-CIT binding showed significant age affects in patients with de novo PD after standardization for the severity of disease. The age effects were significantly smaller in PD patients than those in healthy subjects, but only in the putamen, not in the caudate nucleus. Given that age-related attrition of DA neurons is even in normal striatum, the uneven age effects in the parkinsonian striatum are likely to reflect the superimposition of disease-driven compensation on the aging effect.[PUBLICATION ABSTRACT]
Objective: Dopamine transporter (DAT) imaging shows age-related decline of ligand binding in the normal striatum, a decline attributed to regulatory changes. We investigated if similar changes occur in the striatum of Parkinson's disease (PD) patients, using PET and [ super(18)F]FP-CIT, a ligand for DAT. Methods: We performed [ super(18)F]FP-CIT PET in 39 drug-naive, de novo PD patients (age 56.0 plus or minus 11.6 years, mean plus or minus SD) and 34 healthy control subjects (age 52.3 plus or minus 17.8). Parkinsonism was assessed by UPDRS III and Purdue pegboard. Binding ratios of [ super(18)F]FP-CIT were obtained in the putamen and caudate using the occipital cortex as reference. Results: Mean [ super(18)F]FP-CIT binding ratios in PD were 3.76 plus or minus 0.74 (mean plus or minus SD) in the putamen and 6.80 plus or minus 1.05 in the caudate nucleus, significantly smaller than those in the healthy control (9.20 plus or minus 1.38, 8.66 plus or minus 1.12, respectively; p < 0.001 vs. healthy control for both). Regression analysis of [ super(18)F]FP-CIT binding ratios on age in healthy subjects showed significant correlations in the putamen (p < 0.001) and caudate nucleus (p < 0.001). Similar analysis in PD patients also showed significant correlations in the putamen (p = 0.015) and caudate nucleus (p = 0.018). The slope of regression in the putamen was -0.061 in the healthy control and -0.017 in PD, with significant differences between the two groups (p = 0.0003). In contrast, the regression slope in the caudate nucleus was -0.040 in the healthy control group, and -0.032 in the PD group with no significant differences between the two groups. Conclusions: Striatal [ super(18)F]FP-CIT binding showed significant age affects in patients with de novo PD after standardization for the severity of disease. The age effects were significantly smaller in PD patients than those in healthy subjects, but only in the putamen, not in the caudate nucleus. Given that age-related attrition of DA neurons is even in normal striatum, the uneven age effects in the parkinsonian striatum are likely to reflect the superimposition of disease-driven compensation on the aging effect.
Author Kim, Su-Jeong
Yun, Sung-Cheol
Kim, Jae Seung
Oh, Seung Jun
Doudet, Doris
Kim, Hye Ok
Lee, Chong S.
Author_xml – sequence: 1
  givenname: Chong S.
  surname: Lee
  fullname: Lee, Chong S.
  organization: Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine
– sequence: 2
  givenname: Su-Jeong
  surname: Kim
  fullname: Kim, Su-Jeong
  organization: Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine
– sequence: 3
  givenname: Seung Jun
  surname: Oh
  fullname: Oh, Seung Jun
  organization: Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine
– sequence: 4
  givenname: Hye Ok
  surname: Kim
  fullname: Kim, Hye Ok
  organization: Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine
– sequence: 5
  givenname: Sung-Cheol
  surname: Yun
  fullname: Yun, Sung-Cheol
  organization: Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine
– sequence: 6
  givenname: Doris
  surname: Doudet
  fullname: Doudet, Doris
  organization: Department of Medicine/Neurology, University of British Columbia
– sequence: 7
  givenname: Jae Seung
  surname: Kim
  fullname: Kim, Jae Seung
  email: jaeskim@amc.seoul.kr
  organization: Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25008292$$D View this record in MEDLINE/PubMed
BookMark eNp9kc9qFEEQhxuJmE30AbxIgxcvo139Z7rnKEtWAwGDJCeRpranZu242xO7ZwRvvoav55PYyyYgAT3Vob7vR1G_E3aUxkSMPQfxGoSwbwpI0F0jQDfCOdnAI7YA1-qm1UodsYXo6saCs8fspJQbIaQzTj5hx9II4WQnF-zjdaLvlDhuiNMwUJgKHwf-Cdzq8-qyWZ5f8XVMfUwbHhOfvhAvU444zbs9don5a0xlTL9__iq8j4Ww0FP2eMBtoWd385Rdr86ulu-biw_vzpdvL5qg23ZqQOveWEAAi8a0AbUIYS26Vsk1EUkANM4qjSogGrQudA503yph0ChAdcpeHXJv8_htpjL5XSyBtltMNM7FQ6uM0FpJVdGXD9Cbcc6pXlcpabv6TLGnXtxR83pHvb_NcYf5h7__VgXsAQh5LCXT4EOccIpjmjLGrQfh9734Qy--9uL3vXioJjww78P_58iDUyqbNpT_Ovqf0h9Ixpx1
CitedBy_id crossref_primary_10_1007_s12149_022_01818_5
crossref_primary_10_1186_s13550_024_01126_1
crossref_primary_10_1007_s13139_017_0481_x
crossref_primary_10_1097_MNM_0000000000001098
crossref_primary_10_1007_s00415_020_09788_2
crossref_primary_10_1007_s13139_024_00840_x
crossref_primary_10_1038_s41598_019_47026_6
crossref_primary_10_3390_ijms222011234
crossref_primary_10_14802_jmd_15031
crossref_primary_10_3390_cells8080872
crossref_primary_10_1016_j_neurobiolaging_2015_01_016
Cites_doi 10.1212/WNL.51.2_Suppl_2.S2
10.1002/mds.23179
10.1001/archneur.1993.00540020018011
10.1002/syn.20603
10.1016/0014-4886(69)90131-9
10.1016/j.neuropharm.2004.07.010
10.1002/syn.10160
10.1212/WNL.47.3.718
10.1016/S0197-4580(03)00129-5
10.1016/j.nucmedbio.2007.02.007
10.1212/WNL.17.5.427
10.1002/ana.410260407
10.1016/j.nbd.2010.07.012
10.1002/syn.20708
10.1006/exnr.1994.1069
10.1002/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1
10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4
10.1002/ana.22284
10.1002/ana.410280611
10.2967/jnumed.111.095224
10.1212/WNL.48.4.969
10.1016/j.neuroimage.2006.09.022
10.1111/j.1471-4159.1992.tb09766.x
10.1016/j.neurobiolaging.2007.09.009
10.1002/ana.410400609
10.1523/JNEUROSCI.16-10-03507.1996
ContentType Journal Article
Copyright The Japanese Society of Nuclear Medicine 2014
Copyright_xml – notice: The Japanese Society of Nuclear Medicine 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7RV
7TK
7X7
7XB
88E
8AO
8FE
8FG
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9.
KB0
LK8
M0S
M1P
M2O
M7P
MBDVC
NAPCQ
P5Z
P62
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7QO
8FD
FR3
P64
DOI 10.1007/s12149-014-0882-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest
ProQuest Technology Collection
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Research Library
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Central Basic
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
ProQuest Central (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList
MEDLINE
Research Library Prep
Engineering Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1864-6433
EndPage 879
ExternalDocumentID 3507423221
25008292
10_1007_s12149_014_0882_1
Genre Research Support, Non-U.S. Gov't
Journal Article
Feature
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.VR
06C
06D
0R~
0VY
1N0
2.D
203
23M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2WC
2~H
30V
3V.
4.4
406
408
40D
40E
53G
5GY
5VS
67Z
6J9
6NX
7RV
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
8G5
8TC
8UJ
8WZ
95-
95.
95~
96X
A6W
AAAVM
AABHQ
AACDK
AAEWM
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFO
ACGFS
ACHSB
ACHXU
ACIHN
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACSNA
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARAPS
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BAWUL
BBNVY
BBWZM
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BKEYQ
BPHCQ
BVXVI
C1A
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DIK
DNIVK
DPUIP
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
EX3
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRP
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GRRUI
GUQSH
GX1
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
LK8
LLZTM
M1P
M2O
M4Y
M7P
MA-
N9A
NAPCQ
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P2P
P62
P6G
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RNS
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SCLPG
SDE
SDH
SHX
SISQX
SJN
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TEORI
TKC
TR2
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W2D
W48
WJK
WK8
WOW
X7M
XSB
YLTOR
Z45
Z7U
Z7X
Z82
Z83
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
OVT
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7QP
7TK
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
PUEGO
Q9U
7QO
8FD
FR3
P64
ID FETCH-LOGICAL-c466t-144d571a117a556ca40ccb09632beee211a58734a3caa5a78c9814d6305a531a3
IEDL.DBID 8FG
ISSN 0914-7187
IngestDate Fri Sep 05 10:48:48 EDT 2025
Wed Sep 17 13:51:36 EDT 2025
Mon Jul 21 06:04:23 EDT 2025
Thu Apr 24 22:59:11 EDT 2025
Tue Jul 01 02:34:53 EDT 2025
Fri Feb 21 02:36:35 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Dopamine transporter
[
Positron emission tomography
Age
Parkinson’s disease
F]FP-CIT
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c466t-144d571a117a556ca40ccb09632beee211a58734a3caa5a78c9814d6305a531a3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 25008292
PQID 1627900703
PQPubID 54108
PageCount 6
ParticipantIDs proquest_miscellaneous_1635044323
proquest_journals_1627900703
pubmed_primary_25008292
crossref_citationtrail_10_1007_s12149_014_0882_1
crossref_primary_10_1007_s12149_014_0882_1
springer_journals_10_1007_s12149_014_0882_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-11-01
PublicationDateYYYYMMDD 2014-11-01
PublicationDate_xml – month: 11
  year: 2014
  text: 2014-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Annals of nuclear medicine
PublicationTitleAbbrev Ann Nucl Med
PublicationTitleAlternate Ann Nucl Med
PublicationYear 2014
Publisher Springer Japan
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer Nature B.V
References Martin, Palmer, Patlak, Calne (CR1) 1989; 26
Wilson, Kish (CR28) 1996; 16
de la Fuente-Fernandez, Schulzer, Kuramoto, Cragg, Ramachandiran, Au (CR24) 2011; 69
De La Fuente-Fernandez, Lim, Sossi, Adam, Ruth, Calne (CR23) 2003; 47
Bedard, Larochelle, Parent, Poirier (CR33) 1969; 25
Afonso-Oramas, Cruz-Muros, Barroso-Chinea, Alvarez de la Rosa, Castro-Hernandez, Salas-Hernandez (CR29) 2010; 40
Hoehn, Yahr (CR16) 1967; 17
Tissingh, Booij, Bergmans, Winogrodzka, Janssen, van Royen (CR12) 1998; 39
van Dyck, Seibyl, Malison, Laruelle, Wallace, Zoghbi (CR2) 1995; 36
Roselli, Pisciotta, Pennelli, Aniello, Gigante, De Caro (CR15) 2010; 25
Zahniser, Sorkin (CR8) 2004; 47
Lee, Samii, Sossi, Ruth, Schulzer, Holden (CR9) 2000; 47
Bannon, Whitty (CR30) 1997; 48
Hughes, Daniel, Blankson, Lees (CR14) 1993; 50
Sun, Schriber, Greenia, He, Gitcho, Jagust (CR19) 2007; 34
Troiano, Schulzer, de la Fuente-Fernandez, Mak, McKenzie, Sossi (CR7) 2010; 64
Kish, Shannak, Rajput, Deck, Hornykiewicz (CR26) 1992; 58
Wullner, Pakzaban, Brownell, Hantraye, Burns, Shoup (CR21) 1994; 126
Cruz-Muros, Afonso-Oramas, Abreu, Perez-Delgado, Rodriguez, Gonzalez-Hernandez (CR31) 2009; 30
Lee, Oh, Chi, Kang, Kil, Kim (CR17) 2007; 34
Kazumata, Dhawan, Chaly, Antonini, Margouleff, Belakhlef (CR3) 1998; 39
Wilson, Levey, Rajput, Ang, Guttman, Shannak (CR25) 1996; 47
Tissingh, Bergmans, Booij, Winogrodzka, Stoof, Wolters (CR11) 1997; 24
Vingerhoets, Snow, Schulzer, Morrison, Ruth, Holden, Cooper, Calne (CR20) 1994; 35
Hornykiewicz (CR13) 1998; 51
Oh, Kim, Kim, Shin, Park, Kim, Moon, Oh, Chung, Lee (CR18) 2012; 53
Ishibashi, Ishii, Oda, Kawasaki, Mizusawa, Ishiwata (CR27) 2009; 63
Sawle, Colebatch, Shah, Brooks, Marsden, Frackowiak (CR4) 1990; 28
Marek, Jennings, Seibyl (CR32) 2003; 91
Booij, Bergmans, Winogrodzka, Speelman, Wolters (CR22) 2001; 39
Ishikawa, Dhawan, Kazumata, Chaly, Mandel, Neumeyer (CR6) 1996; 37
Frey, Koeppe, Kilbourn, Vander Borght, Albin, Gilman (CR5) 1996; 40
Salvatore, Apparsundaram, Gerhardt (CR10) 2003; 24
MM Hoehn (882_CR16) 1967; 17
FT Sun (882_CR19) 2007; 34
R Fuente-Fernandez De La (882_CR23) 2003; 47
K Marek (882_CR32) 2003; 91
JM Wilson (882_CR28) 1996; 16
MJ Bannon (882_CR30) 1997; 48
GV Sawle (882_CR4) 1990; 28
O Hornykiewicz (882_CR13) 1998; 51
I Cruz-Muros (882_CR31) 2009; 30
F Roselli (882_CR15) 2010; 25
G Tissingh (882_CR12) 1998; 39
WR Martin (882_CR1) 1989; 26
MF Salvatore (882_CR10) 2003; 24
SJ Kish (882_CR26) 1992; 58
NR Zahniser (882_CR8) 2004; 47
J Booij (882_CR22) 2001; 39
SJ Lee (882_CR17) 2007; 34
K Ishibashi (882_CR27) 2009; 63
FJ Vingerhoets (882_CR20) 1994; 35
AJ Hughes (882_CR14) 1993; 50
CH Dyck van (882_CR2) 1995; 36
K Kazumata (882_CR3) 1998; 39
P Bedard (882_CR33) 1969; 25
U Wullner (882_CR21) 1994; 126
AR Troiano (882_CR7) 2010; 64
T Ishikawa (882_CR6) 1996; 37
KA Frey (882_CR5) 1996; 40
M Oh (882_CR18) 2012; 53
JM Wilson (882_CR25) 1996; 47
CS Lee (882_CR9) 2000; 47
D Afonso-Oramas (882_CR29) 2010; 40
R Fuente-Fernandez de la (882_CR24) 2011; 69
G Tissingh (882_CR11) 1997; 24
References_xml – volume: 51
  start-page: S2
  year: 1998
  end-page: S9
  ident: CR13
  article-title: Biochemical aspects of Parkinson’s disease
  publication-title: Neurology
  doi: 10.1212/WNL.51.2_Suppl_2.S2
– volume: 25
  start-page: 1853
  year: 2010
  end-page: 1859
  ident: CR15
  article-title: Midbrain SERT in degenerative parkinsonisms: a I-FP-CIT SPECT study
  publication-title: Mov Disord
  doi: 10.1002/mds.23179
– volume: 50
  start-page: 140
  year: 1993
  end-page: 148
  ident: CR14
  article-title: A clinicopathologic study of 100 cases of Parkinson’s disease
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1993.00540020018011
– volume: 63
  start-page: 282
  year: 2009
  end-page: 290
  ident: CR27
  article-title: Regional analysis of age-related in dopamine transporters and dopamine D2-like receptors in human striatum
  publication-title: Synapse
  doi: 10.1002/syn.20603
– volume: 25
  start-page: 365
  year: 1969
  end-page: 377
  ident: CR33
  article-title: The nigrostriatal pathway: a correlative study based on neuroanatomical and neurochemical criteria in the cat and the monkey
  publication-title: Exp Neurol
  doi: 10.1016/0014-4886(69)90131-9
– volume: 47
  start-page: 80
  issue: Suppl 1
  year: 2004
  end-page: 91
  ident: CR8
  article-title: Rapid regulation of the dopamine transporter: role in stimulant addiction?
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2004.07.010
– volume: 47
  start-page: 152
  year: 2003
  end-page: 158
  ident: CR23
  article-title: Age and severity of nigrostriatal damage at onset of Parkinson’s disease
  publication-title: Synapse
  doi: 10.1002/syn.10160
– volume: 47
  start-page: 718
  year: 1996
  end-page: 726
  ident: CR25
  article-title: Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson’s disease
  publication-title: Neurology
  doi: 10.1212/WNL.47.3.718
– volume: 24
  start-page: 1147
  year: 2003
  end-page: 1154
  ident: CR10
  article-title: Decreased plasma membrane expression of striatal dopamine transporter in aging
  publication-title: Neurobiol Aging
  doi: 10.1016/S0197-4580(03)00129-5
– volume: 34
  start-page: 345
  year: 2007
  end-page: 351
  ident: CR17
  article-title: One-step high-radiochemical-yield synthesis of [ F]FP-CIT using a protic solvent system
  publication-title: Nucl Med Biol
  doi: 10.1016/j.nucmedbio.2007.02.007
– volume: 17
  start-page: 427
  year: 1967
  end-page: 442
  ident: CR16
  article-title: Parkinsonism: onset, progression and mortality
  publication-title: Neurology
  doi: 10.1212/WNL.17.5.427
– volume: 91
  start-page: 183
  year: 2003
  end-page: 191
  ident: CR32
  article-title: Single-photon emission tomography and dopamine transporter imaging in Parkinson’s disease
  publication-title: Adv Neurol
– volume: 26
  start-page: 535
  year: 1989
  end-page: 542
  ident: CR1
  article-title: Nigrostriatal function in humans studied with positron emission tomography
  publication-title: Ann Neurol
  doi: 10.1002/ana.410260407
– volume: 40
  start-page: 518
  year: 2010
  end-page: 530
  ident: CR29
  article-title: The dopamine transporter is differentially regulated after dopaminergic lesion
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2010.07.012
– volume: 64
  start-page: 146
  year: 2010
  end-page: 151
  ident: CR7
  article-title: Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function
  publication-title: Synapse
  doi: 10.1002/syn.20708
– volume: 126
  start-page: 305
  year: 1994
  end-page: 309
  ident: CR21
  article-title: Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with C-CFT
  publication-title: Exp Neurol
  doi: 10.1006/exnr.1994.1069
– volume: 35
  start-page: 18
  issue: 1
  year: 1994
  end-page: 24
  ident: CR20
  article-title: Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects
  publication-title: J Nucl Med
– volume: 39
  start-page: 1143
  year: 1998
  end-page: 1148
  ident: CR12
  article-title: Iodine-123- -omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson’s disease
  publication-title: J Nucl Med
– volume: 39
  start-page: 101
  year: 2001
  end-page: 108
  ident: CR22
  article-title: Imaging of dopamine transporters with [ I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson’s disease
  publication-title: Synapse
  doi: 10.1002/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1
– volume: 16
  start-page: 3507
  year: 1996
  end-page: 3510
  ident: CR28
  article-title: The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat
  publication-title: J Neurosci
– volume: 47
  start-page: 493
  year: 2000
  end-page: 503
  ident: CR9
  article-title: In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson’s disease
  publication-title: Ann Neurol
  doi: 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4
– volume: 69
  start-page: 803
  year: 2011
  end-page: 810
  ident: CR24
  article-title: Age-specific progression of nigrostriatal dysfunction in Parkinson’s disease
  publication-title: Ann Neurol
  doi: 10.1002/ana.22284
– volume: 28
  start-page: 799
  year: 1990
  end-page: 804
  ident: CR4
  article-title: Striatal function in normal aging: implications for Parkinson’s disease
  publication-title: Ann Neurol
  doi: 10.1002/ana.410280611
– volume: 36
  start-page: 1175
  year: 1995
  end-page: 1181
  ident: CR2
  article-title: Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT
  publication-title: J Nucl Med
– volume: 37
  start-page: 1760
  year: 1996
  end-page: 1765
  ident: CR6
  article-title: Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET
  publication-title: J Nucl Med
– volume: 53
  start-page: 399
  issue: 3
  year: 2012
  end-page: 406
  ident: CR18
  article-title: Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.111.095224
– volume: 48
  start-page: 969
  year: 1997
  end-page: 977
  ident: CR30
  article-title: Age-related and regional differences in dopamine transporter mRNA expression in human midbrain
  publication-title: Neurology
  doi: 10.1212/WNL.48.4.969
– volume: 34
  start-page: 608
  year: 2007
  end-page: 617
  ident: CR19
  article-title: Automated template-based PET region of interest analyses in the aging brain
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2006.09.022
– volume: 58
  start-page: 642
  year: 1992
  end-page: 648
  ident: CR26
  article-title: Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson’s disease
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.1992.tb09766.x
– volume: 39
  start-page: 1521
  year: 1998
  end-page: 1530
  ident: CR3
  article-title: Dopamine transporter imaging with fluorine-18-FPCIT and PET
  publication-title: J Nucl Med
– volume: 30
  start-page: 973
  year: 2009
  end-page: 986
  ident: CR31
  article-title: Aging effects on the dopamine transporter expression and compensatory mechanisms
  publication-title: Neurobiol Aging
  doi: 10.1016/j.neurobiolaging.2007.09.009
– volume: 24
  start-page: 1171
  year: 1997
  end-page: 1174
  ident: CR11
  article-title: [ I]beta-CIT single-photon emission tomography in Parkinson’s disease reveals a smaller decline in dopamine transporters with age than in controls
  publication-title: Eur J Nucl Med
– volume: 40
  start-page: 873
  year: 1996
  end-page: 884
  ident: CR5
  article-title: Presynaptic monoaminergic vesicles in Parkinson’s disease and normal aging
  publication-title: Ann Neurol
  doi: 10.1002/ana.410400609
– volume: 50
  start-page: 140
  year: 1993
  ident: 882_CR14
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1993.00540020018011
– volume: 25
  start-page: 365
  year: 1969
  ident: 882_CR33
  publication-title: Exp Neurol
  doi: 10.1016/0014-4886(69)90131-9
– volume: 30
  start-page: 973
  year: 2009
  ident: 882_CR31
  publication-title: Neurobiol Aging
  doi: 10.1016/j.neurobiolaging.2007.09.009
– volume: 37
  start-page: 1760
  year: 1996
  ident: 882_CR6
  publication-title: J Nucl Med
– volume: 47
  start-page: 493
  year: 2000
  ident: 882_CR9
  publication-title: Ann Neurol
  doi: 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4
– volume: 126
  start-page: 305
  year: 1994
  ident: 882_CR21
  publication-title: Exp Neurol
  doi: 10.1006/exnr.1994.1069
– volume: 58
  start-page: 642
  year: 1992
  ident: 882_CR26
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.1992.tb09766.x
– volume: 40
  start-page: 518
  year: 2010
  ident: 882_CR29
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2010.07.012
– volume: 35
  start-page: 18
  issue: 1
  year: 1994
  ident: 882_CR20
  publication-title: J Nucl Med
– volume: 39
  start-page: 101
  year: 2001
  ident: 882_CR22
  publication-title: Synapse
  doi: 10.1002/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1
– volume: 69
  start-page: 803
  year: 2011
  ident: 882_CR24
  publication-title: Ann Neurol
  doi: 10.1002/ana.22284
– volume: 36
  start-page: 1175
  year: 1995
  ident: 882_CR2
  publication-title: J Nucl Med
– volume: 28
  start-page: 799
  year: 1990
  ident: 882_CR4
  publication-title: Ann Neurol
  doi: 10.1002/ana.410280611
– volume: 39
  start-page: 1143
  year: 1998
  ident: 882_CR12
  publication-title: J Nucl Med
– volume: 25
  start-page: 1853
  year: 2010
  ident: 882_CR15
  publication-title: Mov Disord
  doi: 10.1002/mds.23179
– volume: 48
  start-page: 969
  year: 1997
  ident: 882_CR30
  publication-title: Neurology
  doi: 10.1212/WNL.48.4.969
– volume: 34
  start-page: 345
  year: 2007
  ident: 882_CR17
  publication-title: Nucl Med Biol
  doi: 10.1016/j.nucmedbio.2007.02.007
– volume: 34
  start-page: 608
  year: 2007
  ident: 882_CR19
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2006.09.022
– volume: 40
  start-page: 873
  year: 1996
  ident: 882_CR5
  publication-title: Ann Neurol
  doi: 10.1002/ana.410400609
– volume: 17
  start-page: 427
  year: 1967
  ident: 882_CR16
  publication-title: Neurology
  doi: 10.1212/WNL.17.5.427
– volume: 64
  start-page: 146
  year: 2010
  ident: 882_CR7
  publication-title: Synapse
  doi: 10.1002/syn.20708
– volume: 47
  start-page: 80
  issue: Suppl 1
  year: 2004
  ident: 882_CR8
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2004.07.010
– volume: 51
  start-page: S2
  year: 1998
  ident: 882_CR13
  publication-title: Neurology
  doi: 10.1212/WNL.51.2_Suppl_2.S2
– volume: 47
  start-page: 718
  year: 1996
  ident: 882_CR25
  publication-title: Neurology
  doi: 10.1212/WNL.47.3.718
– volume: 63
  start-page: 282
  year: 2009
  ident: 882_CR27
  publication-title: Synapse
  doi: 10.1002/syn.20603
– volume: 16
  start-page: 3507
  year: 1996
  ident: 882_CR28
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.16-10-03507.1996
– volume: 47
  start-page: 152
  year: 2003
  ident: 882_CR23
  publication-title: Synapse
  doi: 10.1002/syn.10160
– volume: 39
  start-page: 1521
  year: 1998
  ident: 882_CR3
  publication-title: J Nucl Med
– volume: 91
  start-page: 183
  year: 2003
  ident: 882_CR32
  publication-title: Adv Neurol
– volume: 24
  start-page: 1147
  year: 2003
  ident: 882_CR10
  publication-title: Neurobiol Aging
  doi: 10.1016/S0197-4580(03)00129-5
– volume: 53
  start-page: 399
  issue: 3
  year: 2012
  ident: 882_CR18
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.111.095224
– volume: 26
  start-page: 535
  year: 1989
  ident: 882_CR1
  publication-title: Ann Neurol
  doi: 10.1002/ana.410260407
– volume: 24
  start-page: 1171
  year: 1997
  ident: 882_CR11
  publication-title: Eur J Nucl Med
SSID ssj0028582
Score 2.099487
Snippet Objective Dopamine transporter (DAT) imaging shows age-related decline of ligand binding in the normal striatum, a decline attributed to regulatory changes. We...
Dopamine transporter (DAT) imaging shows age-related decline of ligand binding in the normal striatum, a decline attributed to regulatory changes. We...
Objective: Dopamine transporter (DAT) imaging shows age-related decline of ligand binding in the normal striatum, a decline attributed to regulatory changes....
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 874
SubjectTerms Adult
Aged
Aging - physiology
Corpus Striatum - diagnostic imaging
Corpus Striatum - physiopathology
Female
Humans
Imaging
Male
Medicine
Medicine & Public Health
Middle Aged
Nuclear Medicine
Original Article
Parkinson Disease - diagnostic imaging
Parkinson Disease - physiopathology
Positron-Emission Tomography
Radiology
Radiopharmaceuticals - pharmacokinetics
Regression Analysis
Severity of Illness Index
Tropanes - pharmacokinetics
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1JS8QwFH7ICOLFfRk3InhSKpOtaY8ijhuKyAwoIiVNMyBqR5zOxZN_w7_nL_Glk4674LmvaZq8l3wfbwPY6CgR00xrNCSZBYKxLEhRjYOwwVOKiN0o5nKHT07Dg7Y4upAXPo-7V0W7Vy7J8qR-T3ZjiOaR-oqghIVIeUal4yc1GN3ZvzzeG_KsSJY9ovAmdKGGkaqcmT8N8vk6-oYxv_lHy2unOQmtasKDaJPb7X6RbpunL7Uc__lHUzDhYSjZGejNNIzYfAbGTryjfRbO27kr7UTwtCE-5IN0O-SKRs3r5lmwe9gi6U2ZEENucoIgkpT9P4r-vRNzqdRlVtnr80uPeB_QHLSbe63dg8C3XwiMCMMiQKqVSUU1pUpLGRotGsakSHk4S621yBy1jBQXmhutpVaRiSMqshBPEI2Wrfk81PJubheBxGFsJJcODWTIyJDjiRgPC1dYR0lrTR0a1S4kxtcmdy0y7pL3qspurRJcq8StVULrsDl85WFQmOMv4ZVqaxNvo72EhkzFrtwRr8P68DFal3OZ6Nx2-06Gy4YQnKHMwkAlhl9D8OgSk1kdtqrt_TD4b1NZ-pf0Mowzpx9l8uMK1IrHvl1FFFSka17r3wD1WvfS
  priority: 102
  providerName: Springer Nature
Title Uneven age effects of [18F]FP-CIT binding in the striatum of Parkinson’s disease
URI https://link.springer.com/article/10.1007/s12149-014-0882-1
https://www.ncbi.nlm.nih.gov/pubmed/25008292
https://www.proquest.com/docview/1627900703
https://www.proquest.com/docview/1635044323
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1864-6433
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0028582
  issn: 0914-7187
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1864-6433
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0028582
  issn: 0914-7187
  databaseCode: AFBBN
  dateStart: 19970301
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1864-6433
  dateEnd: 20190131
  omitProxy: true
  ssIdentifier: ssj0028582
  issn: 0914-7187
  databaseCode: 7X7
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1864-6433
  dateEnd: 20190131
  omitProxy: true
  ssIdentifier: ssj0028582
  issn: 0914-7187
  databaseCode: BENPR
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Technology Collection
  customDbUrl:
  eissn: 1864-6433
  dateEnd: 20190131
  omitProxy: true
  ssIdentifier: ssj0028582
  issn: 0914-7187
  databaseCode: 8FG
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/technologycollection1
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1864-6433
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0028582
  issn: 0914-7187
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1864-6433
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0028582
  issn: 0914-7187
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1ra9RAcLAtiF_E-urVeqwgCMri7SubfJKzXFqVliI9OREbNpstFGzu2rv7_87sba6VYj8FkkmyzGNnZucF8Pbc6kI0zqEgmYZrKRteIxvzbKBqgRa7t5Jqh4-Os8Ox_joxk3TgNk9pld2eGDfqZurpjPyjyKQtqDmN-jS74jQ1iqKraYTGBmzhhxWldOXlwdrhyk0cFoUqkXIOc9tFNWPpnETfAB1pzaORKf7VS3eMzTuB0qh_yifwOBmObLii9DY8CO1TeHiUQuPP4Me4pWZMDPcHlpI02PSc_TqbL2dM5Gfl7_KE7385ZfVFLGRhFy1D44_FuR2L5SUBUwl0rAZ7N2cpcvMcxuXodP-Qp6EJ3OssW3B0kBpjhRPCOmMy7_TA-xodFSXrEAL6e87kVmmnvHPG2dwXudBNhnLvUB6degGb7bQNO8CKrPBGGdLhDfpR6JnpAkWc2uFYE4LvwaBDWeVTR3EabPGnuumFTFiuEMsVYbkSPXi_fmW2aqdxH_BeR4cqSda8uuGDHrxZP0aZoECHa8N0STDKDLRWEmFerui3_huafFROLHvwoSPorY__bym79y_lFTySxEqxRnEPNhfXy_AajZVF3YcNO7H9yJd92Boe_Pw2wuvn0fHJd7w7lsO_kGrj4A
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxNBEB9qBe2LWL8aW-sWFEFZzH7d3j2UItWQtE3xIZGA2HNvbwsFvUSTUPyn_Bud2dwlSrFvfb65vWW-9jc3OzMAL86tzkTpHBqSKbmWsuQFqjFP2qoQiNi9lVQ73D9NukN9NDKjNfjd1MLQtcrGJ0ZHXY49_SN_KxJpM2pOow4mPzhNjaLsajNCY6EWx-HXJYZs0_3ee5TvSyk7HwaHXV5PFeBeJ8mMYwRRGiucENYZk3in294XiOSVLEIIGBA5k1qlnfLOGWdTn6VClwkahkOFdQrXvQW3tWpr6tVvR6sALzVxOBUewXTHMbVNFjWW6kmMRTBw1zyCWvHvOXgF3F5JzMbzrnMf7tVAlb1baNYmrIXqAdzp16n4h_BpWFHzJ4b-iNWXQtj4nH0-m84nTKRnnS-dj_ywN2DFRSycYRcVQ7DJ4pyQ2fw7EVPJdaw-ezVldaboEQxvhJ2PYb0aV2ELWJZk3ihDmKHEuA0jQZ2hS6H2O9aE4FvQbliW-7qDOQ3S-Javei8Tl3Pkck5czkULXi9fmSzad1xHvNPIIa8teZqv9K4Fe8vHaIOUWHFVGM-JRhnUBiWR5slCfsuvIcSk8mXZgjeNQP9a_H9beXr9Vp7D3e6gf5Kf9E6Pt2FDklrF-sgdWJ_9nIdnCJRmxW7UTgZfb9oc_gBpHhqR
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bSsNAEF1Eofgi3q1WXcEnJdi9ZZPHUg3eKiIWBJGw2WyhoGmx6bu_4e_5Jc6kSVW8gM-ZXNjZyZzD7JkhZL-nZchSYyCQVOpJzlMvgW3s-U2RMEDsVnPUDneu_NOuPL9Td-Wc01F12r0qSU40DdilKcuPhmnv6EP4xgHZAw2WXgERgf7MSUjVyL66vDVlXIEqpkVBTsRDh4Guypo_PeJrYvqGNr9VSosEFC2ShRI50tbE1UtkxmXLpNYpa-Mr5KabYTcmCj8IWp7SoIMevWdB9BBde-2zW5r0Cw0L7WcUcB8tRnbk4yc0Q_VzIQR7e3kd0bJss0q60clt-9QrJyZ4Vvp-7gE7SpVmhjFtlPKtkU1rE2ApgifOOSB7RgVaSCOsMcrowIYBk6kPQW8gGI1YI7PZIHMbhIZ-aJVQmMBTIFFAy2QI8Y29cLRyztZJs1qu2JbtxHGqxWP80QgZVziGFY5xhWNWJwfTW4aTXhp_GTcqH8RlWI1i5nMdYociUSd708sQEFjlMJkbjNFGqKaUgoPN-sR307cB3kMtMa-Tw8qZnx7-26ds_st6l9Suj6P48uzqYovMc9xghXSxQWbz57HbBgyTJzvFPn0HQrniPw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Uneven+age+effects+of+%5B%5Esup+18%5EF%5DFP-CIT+binding+in+the+striatum+of+Parkinson%27s+disease&rft.jtitle=Annals+of+nuclear+medicine&rft.au=Lee%2C+Chong+S&rft.au=Kim%2C+Su-jeong&rft.au=Oh%2C+Seung+Jun&rft.au=Kim%2C+Hye+Ok&rft.date=2014-11-01&rft.pub=Springer+Nature+B.V&rft.issn=0914-7187&rft.eissn=1864-6433&rft.volume=28&rft.issue=9&rft.spage=874&rft_id=info:doi/10.1007%2Fs12149-014-0882-1&rft.externalDocID=3507423221
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-7187&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-7187&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-7187&client=summon